Mr. Genge joined Regenesis Biomedical in early 2007. During his 35 year career, he has held senior financial executive positions in 4 public and 2 private companies, with a particular emphasis in startup companies who experienced rapid growth, initial product approvals and commercial launches in the medical device, life sciences and health care service industries. In particular, Mr. Genge has directed a Sarbanes Oxley compliance program, taken 2 companies through their initial IPO’s, completed numerous public and private equity and debt offerings, negotiated and implemented multiple strategic alliances with major pharmaceutical companies, managed the merger and acquisition of 6 companies, been responsible for directing the reporting for SEC compliance reporting, managed HR, IT, purchasing, insurance, and facilities operations and directed the implementation of major financial systems. Prior to Regenesis Mr. Genge was a Partner with Tatum, LLC, a Financial Services Practice. Prior to that, he served as Vice-President, CFO and Treasurer of Novavax Inc, a public life sciences company. Before Novavax Dennis was Vice-President and Controller at Pyxis Corporation (a subsidiary of Cardinal Health), a medical supply stations company. He also served as Executive Director of Finance and Corporate Controller at Ligand Pharmaceuticals, a biotechnology company, Vice-President and CFO of Ivonyx HomeCare Services, an IV home therapy company and Executive Director/Controller with IMED Corp. an IV pump company. Mr. Genge began his career as an auditor with Ernst and Young in San Diego. Mr. Genge obtained his CPA license in the state of California and holds a Masters of Business Administration and a Bachelor of Administration with an emphasis in Accounting from Western Michigan University.  

    Genetics